Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630.
Cyclin G-associated kinase (GAK), a key player in clathrin-mediated membrane trafficking, is overexpressed in various cancer cells. Here, we report that GAK expression is positively correlated with the Gleason score in surgical specimens from prostate cancer patients. Embryonic fibroblasts from knoc...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/655f82c6fc96407fb4514f6df014720a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:655f82c6fc96407fb4514f6df014720a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:655f82c6fc96407fb4514f6df014720a2021-11-11T08:21:05ZGefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630.1932-620310.1371/journal.pone.0100124https://doaj.org/article/655f82c6fc96407fb4514f6df014720a2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24971999/?tool=EBIhttps://doaj.org/toc/1932-6203Cyclin G-associated kinase (GAK), a key player in clathrin-mediated membrane trafficking, is overexpressed in various cancer cells. Here, we report that GAK expression is positively correlated with the Gleason score in surgical specimens from prostate cancer patients. Embryonic fibroblasts from knockout mice expressing a kinase-dead (KD) form of GAK showed constitutive hyper-phosphorylation of the epidermal growth factor receptor (EGFR). In addition to the well-known EGFR inhibitors gefitinib and erlotinib, the dietary flavonoid luteolin was a potent inhibitor of the Ser/Thr kinase activity of GAK in vitro. Co-administration of luteolin and gefitinib to PC-3 cells had a greater effect on cell viability than administration of either compound alone; this decrease in viability was associated with drastic down-regulation of GAK protein expression. A comprehensive microRNA array analysis revealed increased expression of miR-630 and miR-5703 following treatment of PC-3 cells with luteolin and/or gefitinib, and exogenous overexpression of miR-630 caused growth arrest of these cells. GAK appears to be essential for cell death because co-administration of gefitinib and luteolin to EGFR-deficient U2OS osteosarcoma cells also had a greater effect on cell viability than administration of either compound alone. Taken together, these findings suggest that GAK may be a new therapeutic target for prostate cancer and osteosarcoma.Minami A SakuraiYuki OzakiDaisuke OkuzakiYoko NaitoTowa SasakuraAyumi OkamotoHiroe TabaraTakao InoueMan HagiyamaAkihiko ItoNorikazu YabutaHiroshi NojimaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 6, p e100124 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Minami A Sakurai Yuki Ozaki Daisuke Okuzaki Yoko Naito Towa Sasakura Ayumi Okamoto Hiroe Tabara Takao Inoue Man Hagiyama Akihiko Ito Norikazu Yabuta Hiroshi Nojima Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630. |
| description |
Cyclin G-associated kinase (GAK), a key player in clathrin-mediated membrane trafficking, is overexpressed in various cancer cells. Here, we report that GAK expression is positively correlated with the Gleason score in surgical specimens from prostate cancer patients. Embryonic fibroblasts from knockout mice expressing a kinase-dead (KD) form of GAK showed constitutive hyper-phosphorylation of the epidermal growth factor receptor (EGFR). In addition to the well-known EGFR inhibitors gefitinib and erlotinib, the dietary flavonoid luteolin was a potent inhibitor of the Ser/Thr kinase activity of GAK in vitro. Co-administration of luteolin and gefitinib to PC-3 cells had a greater effect on cell viability than administration of either compound alone; this decrease in viability was associated with drastic down-regulation of GAK protein expression. A comprehensive microRNA array analysis revealed increased expression of miR-630 and miR-5703 following treatment of PC-3 cells with luteolin and/or gefitinib, and exogenous overexpression of miR-630 caused growth arrest of these cells. GAK appears to be essential for cell death because co-administration of gefitinib and luteolin to EGFR-deficient U2OS osteosarcoma cells also had a greater effect on cell viability than administration of either compound alone. Taken together, these findings suggest that GAK may be a new therapeutic target for prostate cancer and osteosarcoma. |
| format |
article |
| author |
Minami A Sakurai Yuki Ozaki Daisuke Okuzaki Yoko Naito Towa Sasakura Ayumi Okamoto Hiroe Tabara Takao Inoue Man Hagiyama Akihiko Ito Norikazu Yabuta Hiroshi Nojima |
| author_facet |
Minami A Sakurai Yuki Ozaki Daisuke Okuzaki Yoko Naito Towa Sasakura Ayumi Okamoto Hiroe Tabara Takao Inoue Man Hagiyama Akihiko Ito Norikazu Yabuta Hiroshi Nojima |
| author_sort |
Minami A Sakurai |
| title |
Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630. |
| title_short |
Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630. |
| title_full |
Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630. |
| title_fullStr |
Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630. |
| title_full_unstemmed |
Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630. |
| title_sort |
gefitinib and luteolin cause growth arrest of human prostate cancer pc-3 cells via inhibition of cyclin g-associated kinase and induction of mir-630. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/655f82c6fc96407fb4514f6df014720a |
| work_keys_str_mv |
AT minamiasakurai gefitinibandluteolincausegrowtharrestofhumanprostatecancerpc3cellsviainhibitionofcyclingassociatedkinaseandinductionofmir630 AT yukiozaki gefitinibandluteolincausegrowtharrestofhumanprostatecancerpc3cellsviainhibitionofcyclingassociatedkinaseandinductionofmir630 AT daisukeokuzaki gefitinibandluteolincausegrowtharrestofhumanprostatecancerpc3cellsviainhibitionofcyclingassociatedkinaseandinductionofmir630 AT yokonaito gefitinibandluteolincausegrowtharrestofhumanprostatecancerpc3cellsviainhibitionofcyclingassociatedkinaseandinductionofmir630 AT towasasakura gefitinibandluteolincausegrowtharrestofhumanprostatecancerpc3cellsviainhibitionofcyclingassociatedkinaseandinductionofmir630 AT ayumiokamoto gefitinibandluteolincausegrowtharrestofhumanprostatecancerpc3cellsviainhibitionofcyclingassociatedkinaseandinductionofmir630 AT hiroetabara gefitinibandluteolincausegrowtharrestofhumanprostatecancerpc3cellsviainhibitionofcyclingassociatedkinaseandinductionofmir630 AT takaoinoue gefitinibandluteolincausegrowtharrestofhumanprostatecancerpc3cellsviainhibitionofcyclingassociatedkinaseandinductionofmir630 AT manhagiyama gefitinibandluteolincausegrowtharrestofhumanprostatecancerpc3cellsviainhibitionofcyclingassociatedkinaseandinductionofmir630 AT akihikoito gefitinibandluteolincausegrowtharrestofhumanprostatecancerpc3cellsviainhibitionofcyclingassociatedkinaseandinductionofmir630 AT norikazuyabuta gefitinibandluteolincausegrowtharrestofhumanprostatecancerpc3cellsviainhibitionofcyclingassociatedkinaseandinductionofmir630 AT hiroshinojima gefitinibandluteolincausegrowtharrestofhumanprostatecancerpc3cellsviainhibitionofcyclingassociatedkinaseandinductionofmir630 |
| _version_ |
1718439313809604608 |